211 related articles for article (PubMed ID: 1718035)
1. Suppression of the immune response by a soluble complement receptor of B lymphocytes.
Hebell T; Ahearn JM; Fearon DT
Science; 1991 Oct; 254(5028):102-5. PubMed ID: 1718035
[TBL] [Abstract][Full Text] [Related]
2. Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19.
Matsumoto AK; Kopicky-Burd J; Carter RH; Tuveson DA; Tedder TF; Fearon DT
J Exp Med; 1991 Jan; 173(1):55-64. PubMed ID: 1702139
[TBL] [Abstract][Full Text] [Related]
3. Molecular interactions of complement receptors on B lymphocytes: a CR1/CR2 complex distinct from the CR2/CD19 complex.
Tuveson DA; Ahearn JM; Matsumoto AK; Fearon DT
J Exp Med; 1991 May; 173(5):1083-9. PubMed ID: 1708808
[TBL] [Abstract][Full Text] [Related]
4. The CD19 complex of B lymphocytes. Activation of phospholipase C by a protein tyrosine kinase-dependent pathway that can be enhanced by the membrane IgM complex.
Carter RH; Tuveson DA; Park DJ; Rhee SG; Fearon DT
J Immunol; 1991 Dec; 147(11):3663-71. PubMed ID: 1719083
[TBL] [Abstract][Full Text] [Related]
5. The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity.
Fearon DT; Carter RH
Annu Rev Immunol; 1995; 13():127-49. PubMed ID: 7542009
[TBL] [Abstract][Full Text] [Related]
6. Functional dissection of the CD21/CD19/TAPA-1/Leu-13 complex of B lymphocytes.
Matsumoto AK; Martin DR; Carter RH; Klickstein LB; Ahearn JM; Fearon DT
J Exp Med; 1993 Oct; 178(4):1407-17. PubMed ID: 7690834
[TBL] [Abstract][Full Text] [Related]
7. Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21).
Ahearn JM; Fearon DT
Adv Immunol; 1989; 46():183-219. PubMed ID: 2551147
[No Abstract] [Full Text] [Related]
8. Ligation of membrane immunoglobulin leads to inactivation of the signal-transducing ability of membrane immunoglobulin, CD19, CD21, and B-cell gp95.
Rijkers GT; Griffioen AW; Zegers BJ; Cambier JC
Proc Natl Acad Sci U S A; 1990 Nov; 87(22):8766-70. PubMed ID: 1701054
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory and immunosuppressive effects of recombinant soluble complement receptors.
Fearon DT
Clin Exp Immunol; 1991 Oct; 86 Suppl 1(Suppl 1):43-6. PubMed ID: 1718643
[TBL] [Abstract][Full Text] [Related]
10. Structure and signalling functions of C3 receptors on human B cells.
Frade R
Semin Immunol; 1990 Mar; 2(2):159-64. PubMed ID: 2151800
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of the stimulation of complement receptors CR1 (CD35) and CR2 (CD21) on cell proliferation and intracellular Ca2+ mobilization of chronic lymphocytic leukemia B cells.
Hivroz C; Fischer E; Kazatchkine MD; Grillot-Courvalin C
J Immunol; 1991 Mar; 146(6):1766-72. PubMed ID: 1826011
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Epstein-Barr virus infection in vitro and in vivo by soluble CR2 (CD21) containing two short consensus repeats.
Moore MD; Cannon MJ; Sewall A; Finlayson M; Okimoto M; Nemerow GR
J Virol; 1991 Jul; 65(7):3559-65. PubMed ID: 1645784
[TBL] [Abstract][Full Text] [Related]
13. The CD19-CR2-TAPA-1 complex, CD45 and signaling by the antigen receptor of B lymphocytes.
Fearon DT
Curr Opin Immunol; 1993 Jun; 5(3):341-8. PubMed ID: 7688513
[TBL] [Abstract][Full Text] [Related]
14. Deficiencies of human C3 complement receptors type 1 (CR1, CD35) and type 2 (CR2, CD21).
Kazatchkine MD; Fearon DT
Immunodefic Rev; 1990; 2(1):17-41. PubMed ID: 2164822
[TBL] [Abstract][Full Text] [Related]
15. Evidence for an important interaction between a complement-derived CD21 ligand on follicular dendritic cells and CD21 on B cells in the initiation of IgG responses.
Qin D; Wu J; Carroll MC; Burton GF; Szakal AK; Tew JG
J Immunol; 1998 Nov; 161(9):4549-54. PubMed ID: 9794381
[TBL] [Abstract][Full Text] [Related]
16. The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules.
Bradbury LE; Kansas GS; Levy S; Evans RL; Tedder TF
J Immunol; 1992 Nov; 149(9):2841-50. PubMed ID: 1383329
[TBL] [Abstract][Full Text] [Related]
17. Role of CR2 in the human adult and neonatal in vitro antibody response to type 4 pneumococcal polysaccharide.
Griffioen AW; Toebes EA; Zegers BJ; Rijkers GT
Cell Immunol; 1992 Aug; 143(1):11-22. PubMed ID: 1535831
[TBL] [Abstract][Full Text] [Related]
18. The complement system and adaptive immunity.
Fearon DT
Semin Immunol; 1998 Oct; 10(5):355-61. PubMed ID: 9799710
[TBL] [Abstract][Full Text] [Related]
19. Human complement receptor type 2 (CR2/CD21) transgenic mice provide an in vivo model to study immunoregulatory effects of receptor antagonists.
Kulik L; Chen K; Huber BT; Holers VM
Mol Immunol; 2011 Mar; 48(6-7):883-94. PubMed ID: 21269698
[TBL] [Abstract][Full Text] [Related]
20. Immunoregulatory functions of complement: structural and functional studies of complement receptor type 1 (CR1; CD35) and type 2 (CR2; CD21).
Fearon DT; Klickstein LB; Wong WW; Wilson JG; Moore FD; Weis JJ; Weis JH; Jack RM; Carter RH; Ahearn JA
Prog Clin Biol Res; 1989; 297():211-20. PubMed ID: 2531419
[No Abstract] [Full Text] [Related]
[Next] [New Search]
